Newsletter
Newsletter Support JNS

Republican Jewish Coalition endorses Julie Fedorchak for North Dakota House seat

The RJC points to the candidate’s “steadfast and consistent backing of Israel against its fight against Hamas.”

Julie Fedorchak of North Dakota. Source: Julie Fedorchak for Congress/Facebook.
Julie Fedorchak of North Dakota. Source: Julie Fedorchak for Congress/Facebook.

In an unusual decision to endorse a candidate in a primary election, the Republican Jewish Coalition on Monday announced its backing for Julie Fedorchak’s bid for a seat in the House of Representatives.

“Although there are other candidates in the race, there are only two that have a chance to win,” wrote RJC national chairman Norm Coleman and CEO Matt Brooks. “In contrast to her principal opponent, Julie Fedorchak stands firmly against Democrats’ efforts to short-change national defense.”

Fedorchak, a North Dakota Public Service commissioner, has “an outstanding record of delivering results,” they explained.

Furthermore, they added, “Fedorchak has been a steadfast and consistent backer of Israel in its fight against Hamas. Her opponent recently said ‘there’s no place’ for American assistance to Israel in his ideology—before an apparent reversal that leaves his commitment in serious doubt.”

Korn stated that the vote came a “consequential moment for the Jewish people and the State of Israel.”
The ordinance was proposed after anti-Israel activists repeatedly protested outside the private residence of Rep. Adam Smith.
Sarah Levin, of Jews Indigenous to the Middle East and North Africa, told JNS that “educators are being trained on materials that erase and rewrite Jewish history.”
The U.K. had in 2025 the highest per capita rate of antisemitic assaults of any country with a large Jewish community.
“No Jewish community in this country has been left unscathed over the past several years,” said B’nai Brith Canada’s CEO.
Dawas Hassun, a Beit Imrin resident in his 50s, intentionally hit an ATV carrying three Israelis, according to police.